Adirondack Trust Company’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-1,386
Closed -$137K 367
2019
Q3
$137K Sell
1,386
-105
-7% -$9.98K 0.1% 115
2019
Q2
$138K Sell
1,491
-30
-2% -$2.85K 0.1% 118
2019
Q1
$144K Sell
1,521
-630
-29% -$55.1K 0.1% 109
2018
Q4
$137K Sell
2,151
-1,223
-36% -$90.3K 0.11% 104
2018
Q3
$302K Sell
3,374
-780
-19% -$68.9K 0.2% 81
2018
Q2
$330K Sell
4,154
-140
-3% -$11.6K 0.23% 75
2018
Q1
$374K Sell
4,294
-213
-5% -$20.4K 0.27% 71
2017
Q4
$470K Sell
4,507
-235
-5% -$26.5K 0.34% 63
2017
Q3
$691K Buy
4,742
+245
+5% +$33.4K 0.54% 48
2017
Q2
$584K Sell
4,497
-1,840
-29% -$225K 0.47% 51
2017
Q1
$788K Sell
6,337
-1,055
-14% -$126K 0.55% 46
2016
Q4
$855K Buy
7,392
+62
+0.8% +$6.91K 0.6% 45
2016
Q3
$766K Buy
7,330
+315
+4% +$34.1K 0.55% 47
2016
Q2
$691K Sell
7,015
-48
-0.7% -$4.96K 0.49% 50
2016
Q1
$707K Sell
7,063
-40
-0.6% -$4.12K 0.52% 49
2015
Q4
$713K Buy
7,103
+140
+2% +$16.2K 0.56% 49
2015
Q3
$753K Buy
6,963
+3,018
+77% +$375K 0.61% 45
2015
Q2
$457K Buy
3,945
+485
+14% +$55.4K 0.34% 67
2015
Q1
$399K Buy
3,460
+140
+4% +$16.7K 0.3% 67
2014
Q4
$371K Buy
3,320
+20
+0.6% +$2.11K 0.28% 72
2014
Q3
$313K Buy
3,300
+90
+3% +$8.12K 0.24% 75
2014
Q2
$276K Buy
3,210
+2,770
+630% +$211K 0.21% 80
2014
Q1
$31K Hold
440
0.02% 165
2013
Q4
$37K Hold
440
0.03% 151
2013
Q3
$34K Buy
440
+220
+100% +$15.4K 0.03% 152
2013
Q2
$13K Buy
+220
New +$13.2K 0.01% 202

Other funds holding CELG

Adirondack Trust Company's CELG Position: Q4 2019 in Review

Adirondack Trust Company sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 1,386 shares — an estimated $137K sold.

Adirondack Trust Company first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $855K in Q4 2016. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Adirondack Trust Company reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Adirondack Trust Company sold 1,386 Celgene Corp shares in Q4 2019, an estimated $137K.
  • Adirondack Trust Company first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Adirondack Trust Company's Celgene Corp position peaked at $855K in Q4 2016.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Adirondack Trust Company's 13F filing for Q4 2019, filed 11 Feb 2020.